Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gad Perry

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
BJU International|August 18, 2005
Long-term side-effects of intermittent androgen suppression therapy in prostate cancer: results of a phase II studyShawn Malone, Gad Perry, Roanne Segal, et al.
Brachytherapy|December 31, 2013
Real-time measurement of urethral dose and position during permanent seed implantation for prostate brachytherapyAmanda J Cherpak, Joanna E Cygler, Choan E, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 15, 2006
Feasibility study of using MOSFET detectors for in vivo dosimetry during permanent low-dose-rate prostate implantsJoanna E Cygler, Abdelhamid Saoudi, Gad Perry, et al.
ILAR Journal|August 2, 2013
The ethics of wildlife research: a nine R theoryHoward J Curzer, Mark C Wallace, Gad Perry, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 4, 2011
Clinical use of a novel in vivo 4D monitoring system for simultaneous patient motion and dose measurementsAmanda J Cherpak, Joanna E Cygler, Steve Andrusyk, et al.
International Journal of Radiation Oncology, Biology, Physics|August 19, 2008
Final report of multicenter Canadian Phase III randomized trial of 3 versus 8 months of neoadjuvant androgen deprivation therapy before conventional-dose radiotherapy for clinically localized prostate cancerJuanita Crook, Charles Ludgate, Shawn Malone, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2007
Mature results of the Ottawa phase II study of intermittent androgen-suppression therapy in prostate cancer: clinical predictors of outcomeShawn Malone, Gad Perry, Libni Eapen, et al.
Peerj|July 1, 2024
Genetic characterization of the prion protein gene in camels (<i>Camelus</i>) with comments on the evolutionary history of prion disease in CetartiodactylaEmily A Wright, Madison B Reddock, Emma K Roberts, et al.
Brachytherapy|August 12, 2019
Dosimetric and radiobiological investigation of permanent implant prostate brachytherapy based on Monte Carlo calculationsAli-Reza Mehan Haidari, Nelson Miksys, Paul Soubiran, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 2004
Report of a multicenter Canadian phase III randomized trial of 3 months vs. 8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancerJuanita Crook, Charles Ludgate, Shawn Malone, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
BJU International|August 18, 2005
Long-term side-effects of intermittent androgen suppression therapy in prostate cancer: results of a phase II studyShawn Malone, Gad Perry, Roanne Segal, et al.
Brachytherapy|December 31, 2013
Real-time measurement of urethral dose and position during permanent seed implantation for prostate brachytherapyAmanda J Cherpak, Joanna E Cygler, Choan E, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 15, 2006
Feasibility study of using MOSFET detectors for in vivo dosimetry during permanent low-dose-rate prostate implantsJoanna E Cygler, Abdelhamid Saoudi, Gad Perry, et al.
ILAR Journal|August 2, 2013
The ethics of wildlife research: a nine R theoryHoward J Curzer, Mark C Wallace, Gad Perry, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 4, 2011
Clinical use of a novel in vivo 4D monitoring system for simultaneous patient motion and dose measurementsAmanda J Cherpak, Joanna E Cygler, Steve Andrusyk, et al.
International Journal of Radiation Oncology, Biology, Physics|August 19, 2008
Final report of multicenter Canadian Phase III randomized trial of 3 versus 8 months of neoadjuvant androgen deprivation therapy before conventional-dose radiotherapy for clinically localized prostate cancerJuanita Crook, Charles Ludgate, Shawn Malone, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2007
Mature results of the Ottawa phase II study of intermittent androgen-suppression therapy in prostate cancer: clinical predictors of outcomeShawn Malone, Gad Perry, Libni Eapen, et al.
Peerj|July 1, 2024
Genetic characterization of the prion protein gene in camels (<i>Camelus</i>) with comments on the evolutionary history of prion disease in CetartiodactylaEmily A Wright, Madison B Reddock, Emma K Roberts, et al.
Brachytherapy|August 12, 2019
Dosimetric and radiobiological investigation of permanent implant prostate brachytherapy based on Monte Carlo calculationsAli-Reza Mehan Haidari, Nelson Miksys, Paul Soubiran, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 2004
Report of a multicenter Canadian phase III randomized trial of 3 months vs. 8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancerJuanita Crook, Charles Ludgate, Shawn Malone, et al.
Pageof 3